- Home
- MDRR vs COCP Comparison
MDRR vs COCP Comparison
Compare MDRR & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDRR
- COCP
- Stock Information
- Founded
- MDRR 2015
- COCP N/A
- Country
- MDRR United States
- COCP United States
- Employees
- MDRR N/A
- COCP N/A
- Industry
- MDRR Real Estate Investment Trusts
- COCP Biotechnology: Pharmaceutical Preparations
- Sector
- MDRR Real Estate
- COCP Health Care
- Exchange
- MDRR Nasdaq
- COCP Nasdaq
- Market Cap
- MDRR 13.9M
- COCP 15.3M
- IPO Year
- MDRR 2018
- COCP N/A
- Fundamental
- Price
- MDRR $12.53
- COCP $1.43
- Analyst Decision
- MDRR
- COCP Strong Buy
- Analyst Count
- MDRR 0
- COCP 1
- Target Price
- MDRR N/A
- COCP $7.00
- AVG Volume (30 Days)
- MDRR 1.2K
- COCP 17.0K
- Earning Date
- MDRR 05-08-2025
- COCP 03-31-2025
- Dividend Yield
- MDRR 1.72%
- COCP N/A
- EPS Growth
- MDRR N/A
- COCP N/A
- EPS
- MDRR 0.02
- COCP N/A
- Revenue
- MDRR $9,735,127.00
- COCP N/A
- Revenue This Year
- MDRR N/A
- COCP N/A
- Revenue Next Year
- MDRR N/A
- COCP N/A
- P/E Ratio
- MDRR $659.89
- COCP N/A
- Revenue Growth
- MDRR N/A
- COCP N/A
- 52 Week Low
- MDRR $10.90
- COCP $1.35
- 52 Week High
- MDRR $15.00
- COCP $3.26
- Technical
- Relative Strength Index (RSI)
- MDRR 49.30
- COCP 34.72
- Support Level
- MDRR $12.36
- COCP $1.38
- Resistance Level
- MDRR $12.96
- COCP $1.49
- Average True Range (ATR)
- MDRR 0.16
- COCP 0.10
- MACD
- MDRR 0.01
- COCP -0.00
- Stochastic Oscillator
- MDRR 36.62
- COCP 12.82
About MDRR Medalist Diversified REIT Inc.
Medalist Diversified REIT Inc is engaged in the acquisition, reposition, renovation, leasing, and managing of income-producing properties with a focus on commercial properties, including flex-industrial and retail properties, multi-family residential properties, and hotel properties. The company operates as a UPREIT and owns properties through its subsidiary, Medalist Diversified Holdings, LP. Its principal objectives include sourcing value-added Investments in markets in which it maintains deep industry relationships and local market knowledge and the creation of value for stockholders by utilizing its relationships and local knowledge of commercial real estate investment, management, and disposition.
About COCP Cocrystal Pharma Inc.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first- and-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).